House BIOTech caucus is weighing IP security and AI-enabled biotech policy
Rep. Bill Foster (D-IL) arrives for a Democratic caucus meeting on Capitol Hill on September 1, 2026 in Washington, DC. Andrew Harnik/Getty Images
ByAlexandra Kelley,
Staff Correspondent, Nextgov/FCW
September 3, 2026 12:42 PM ET
Lawmakers on the caucus say they won’t push any new legislation forward before the end of the year, but they spotlit intellectual property protection and AI-enabled gene synthesis as concerns.
The bipartisan House BIOTech Caucus is not slated to put any new legislation forward before the end of the year, saying that the bipartisan group is still holding “a lot of hearings" and “developing ideas” about regulatory approaches to the biotechnology industry.
Reps. Bill Foster, D-Ill., and Pete Sessions, R-Texas, who are members of the caucus, spoke on Wednesday during the Identity Week America conference in Washington, D.C., about the need for digital identity verification as a means to prevent abuse...
Copyright of this story solely belongs to nextgov.com. To see the full text click HERE
